Functional and Bioactive Benefits of Selected Microalgal Hydrolysates Assessed In Silico and In Vitro
Marine Drugs · 22.01.2025 · 23 (2) · 53
DOI: 10.3390/md23020053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 22.01.2025. Verfasst von Elena Aurino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Ingegneria Chimica, dei Materiali, e della Produzione Industriale, Università degli Studi di Napoli 'Federico II', Piazzale Tecchio, …. Hauptthemen laut MEDLINE: Microalgae, Chlorella, Scenedesmus, Peptides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North West Europe (NWE) IDEA project, EU Interreg: Northwest Europe (NWE), European Union—NextGenerationEU “Centro Nazionale Biodiversità CN5”—CUP.
Abstract (Originalsprache)
BIOPEP-UWM, a peptide database, contains 5128 peptides from a myriad of resources. Five listed peptides are Angiotensin-I-converting enzyme (ACE-1; EC3.4.15.1) inhibitory peptides derived from a red alga, while two from Chlorella vulgaris have anti-cancer and antioxidative bioactivities. Herein, we describe a process combining hydrolysis with two enzymes, Alcalase and Viscozyme, and filtration to generate protein-rich, bioactive peptide-containing hydrolysates from mixed species of Chlorella sp. and Scenedesmus sp. The potential of generated algal hydrolysates to act as food ingredients was determined by assessment of their techno-functional (foaming, emulsification, solubility, water holding, and oil holding capacity) properties. Bioactive screening of hydrolysates in vitro combined with mass spectrometry (MS) and in silico predictions identified bioactive and functional hydrolysates and six novel peptides. Peptides derived from Chlorella mix have the sequences YDYIGNNPAKGGLF and YIGNNPAKGGLF with predicted anti-inflammatory (medium confidence) and umami potential. Peptides from Scenedesmus mix have sequences IEWYGPDRPKFL, RSPTGEIIFGGETM, TVQIPGGERVPFLF, and IEWYGPDRPKFLGPF with predicted anti-inflammatory, anti-diabetic, and umami attributes. Such microalgal hydrolysates could provide essential amino acids to consumers as well as tertiary health benefits to improve human global health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Ingegneria Chimica, dei Materiali, e della Produzione Industriale, Università degli Studi di Napoli 'Federico II', Piazzale Tecchio, 80, 80125 Naples, Italy.
- Food BioSciences, Teagasc Food Research Centre, Ashtown, D15 DY05 Dublin, Ireland.
- Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Avenue Agustín Escardino 7, 46980 Paterna, Spain.
- Institute of Bio- and Geosciences, IBG-2-Plant Sciences Forschungszentrum Jülich GmbH, Wilhelm-Johnen-Str., 52428 Jülich, Germany.
- Stadt Erftstadt, Stabsstelle Klimaschutz, Holzdamm 10, 50374 Erftstadt, Germany.
ORCID-Profile: Leticia Mora, Antonio Marzocchella, Christina M Kuchendorf
Förderung
- North West Europe (NWE) IDEA project
- EU Interreg: Northwest Europe (NWE)
- European Union—NextGenerationEU “Centro Nazionale Biodiversità CN5”—CUP
Zitieren
APA
Aurino, E., Mora, L., Marzocchella, A., Kuchendorf, C. M., Ackermann, B., & Hayes, M. (2025). Functional and Bioactive Benefits of Selected Microalgal Hydrolysates Assessed In Silico and In Vitro. Marine Drugs, 23(2), 53. https://doi.org/10.3390/md23020053
Vancouver
Aurino E, Mora L, Marzocchella A, Kuchendorf CM, Ackermann B, Hayes M. Functional and Bioactive Benefits of Selected Microalgal Hydrolysates Assessed In Silico and In Vitro. Marine Drugs. 2025;23(2):53. doi:10.3390/md23020053
BibTeX
@article{Aurino2025,
author = {Aurino, Elena and Mora, Leticia and Marzocchella, Antonio and Kuchendorf, Christina M and Ackermann, Bärbel and Hayes, Maria},
title = {Functional and Bioactive Benefits of Selected Microalgal Hydrolysates Assessed In Silico and In Vitro},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {2},
pages = {53},
doi = {10.3390/md23020053}
}
EUVIMED